Analysts think FBRX stock price could increase by 442%
Jun 14, 2024, 6:29 AM
-10.44%
What does FBRX do
Forte Biosciences, Inc., a Dallas-based biopharmaceutical company with nine employees, specializes in dermatology products and services, having gone public in 2017. The company is developing FB-102, a molecule aimed at treating autoimmune conditions like GvHD, vitiligo, and alopecia areata, through preclinical trials.
5 analysts think FBRX stock price will increase by 441.59%. The current median analyst target is $3.06 compared to a current stock price of $0.56. The lowest analysts target is $2.78 and the highest analyst target is $4.20.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
